BioSpace News Archive

Bayer announces the launch of Test Your Cancer, a global educational campaign that harnesses the creative power of imagination to help cancer patients better understand that genomic cancer testing is a crucial step in a diagnosis, painting a more precise picture of a person’s individual cancer.

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company.

Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing proprietary liquid biopsy tests that provide clinically actionable information to physicians to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three months ended March 31, 2019 after the market closes on Wednesday, May 8, 2019.

IVERIC bio (Nasdaq:ISEE) today announced that it will report its first quarter 2019 financial and operating results on Wednesday, May 8, 2019

As the most accessible health care providers in the community, and also among the most trusted, pharmacists can play an important role as part of patients’ care teams to help address the growing need for mental health resources.

Henry Schein, Inc. announced that the Company will present at three conferences in May

Aimmune Therapeutics, Inc. announced that it will host a conference call on Wednesday, May 8, 2019, at 4:30 p.m. ET to discuss its financial results for the quarter ended March 31, 2019, and recent operational highlights.

Collaboration Set to Bring Evidence-based Cancer Rehabilitation Services to Region

Rainier Therapeutics, Inc., a privately held clinical stage drug development company, today announced the appointment of Gary Christianson, PE, as Chief Technical Officer.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2019 and reviewed recent business highlights.